Chinese Clinical Oncology : Impact Factor & More
eISSN: 2304-3873pISSN: 2304-3865
Share this on:
Key Metrics
CiteScore 
4.2
SJR
Q3Oncology
SNIP
1.03
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Chinese Clinical Oncology
Chinese Clinical Oncology Journal Specifications
| Overview | |
| Publisher | AME PUBLISHING COMPANY |
| Language | English |
| Frequency | Quarterly |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Chinese Clinical Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Chinese Clinical Oncology
Small cell lung cancer: a therapeutic update in the era of immunotherapy and beyond-a narrative review.
- 1 Apr 2026
- Chinese clinical oncology
Advancing precision oncology through innovative and adaptive master protocol designs: statistical, operational, and regulatory perspectives.
- 1 Apr 2026
- Chinese clinical oncology
Impact of neoadjuvant chemotherapy vs. upfront surgery on survival in early-onset colorectal cancer-a single centre experience.
- 1 Apr 2026
- Chinese clinical oncology
Hormone therapy in younger women: reassessing risk narratives in the era of precision menopausal care.
- 1 Apr 2026
- Chinese clinical oncology
Fos-related antigen 1 is required for Helicobacter pylori-induced inflammatory response in gastric epithelial cells through NF-κB pathway.
- 1 Apr 2026
- Chinese clinical oncology
Role of androgen receptor signaling in chemoresistance in urothelial cancer: a narrative review.
- 1 Apr 2026
- Chinese clinical oncology
Small cell lung cancer: a therapeutic update in the era of immunotherapy and beyond-a narrative review.
- 1 Apr 2026
- Chinese clinical oncology
Advancing precision oncology through innovative and adaptive master protocol designs: statistical, operational, and regulatory perspectives.
- 1 Apr 2026
- Chinese clinical oncology
Impact of neoadjuvant chemotherapy vs. upfront surgery on survival in early-onset colorectal cancer-a single centre experience.
- 1 Apr 2026
- Chinese clinical oncology
Hormone therapy in younger women: reassessing risk narratives in the era of precision menopausal care.
- 1 Apr 2026
- Chinese clinical oncology
Fos-related antigen 1 is required for Helicobacter pylori-induced inflammatory response in gastric epithelial cells through NF-κB pathway.
- 1 Apr 2026
- Chinese clinical oncology
Role of androgen receptor signaling in chemoresistance in urothelial cancer: a narrative review.
- 1 Apr 2026
- Chinese clinical oncology
FAQs on Chinese Clinical Oncology
How long has Chinese Clinical Oncology been actively publishing? 
What is the publishing frequency of Chinese Clinical Oncology?
How many articles did Chinese Clinical Oncology publish last year?
What is the eISSN & pISSN for Chinese Clinical Oncology?
What is Citescore for Chinese Clinical Oncology?
What is SNIP score for Chinese Clinical Oncology?
What is the SJR for Chinese Clinical Oncology?
Who is the publisher of Chinese Clinical Oncology?
